Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Levodopa‐dyskinesia incidence by age of Parkinson's disease onset

Identifieur interne : 003864 ( Main/Exploration ); précédent : 003863; suivant : 003865

Levodopa‐dyskinesia incidence by age of Parkinson's disease onset

Auteurs : Neeraj Kumar [États-Unis] ; Jay A. Van Gerpen [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis]

Source :

RBID : ISTEX:218E7B52AA5A138757B5D46B9F3208CC4C6E7C11

English descriptors

Abstract

We assessed the 5‐year risk of levodopa‐induced dyskinesias by age of Parkinson's disease (PD) onset in a population‐based cohort. The medical records linkage system of the Rochester Epidemiology project was used to identify residents of Olmsted County, Minnesota, with incident PD for the period 1976 through 1990. In this population‐based study, the 5‐year dyskinesia incidence declined with age. With PD onset after 70 years of age, the incidence was 16%. With onset from 40 to 59 years of age, the incidence was higher at 50%. These incidence data may overestimate the functional importance, because patients with minimal or reversible dyskinesias were counted. © 2004 Movement Disorder Society

Url:
DOI: 10.1002/mds.20360


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Levodopa‐dyskinesia incidence by age of Parkinson's disease onset</title>
<author>
<name sortKey="Kumar, Neeraj" sort="Kumar, Neeraj" uniqKey="Kumar N" first="Neeraj" last="Kumar">Neeraj Kumar</name>
</author>
<author>
<name sortKey="Van Gerpen, Jay A" sort="Van Gerpen, Jay A" uniqKey="Van Gerpen J" first="Jay A." last="Van Gerpen">Jay A. Van Gerpen</name>
</author>
<author>
<name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
</author>
<author>
<name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:218E7B52AA5A138757B5D46B9F3208CC4C6E7C11</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20360</idno>
<idno type="url">https://api.istex.fr/document/218E7B52AA5A138757B5D46B9F3208CC4C6E7C11/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003531</idno>
<idno type="wicri:Area/Istex/Curation">003531</idno>
<idno type="wicri:Area/Istex/Checkpoint">002272</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Kumar N:levodopa:dyskinesia:incidence</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15580606</idno>
<idno type="wicri:Area/PubMed/Corpus">003196</idno>
<idno type="wicri:Area/PubMed/Curation">003196</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003077</idno>
<idno type="wicri:Area/Ncbi/Merge">001105</idno>
<idno type="wicri:Area/Ncbi/Curation">001105</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001105</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Kumar N:levodopa:dyskinesia:incidence</idno>
<idno type="wicri:Area/Main/Merge">004F49</idno>
<idno type="wicri:Area/Main/Curation">003864</idno>
<idno type="wicri:Area/Main/Exploration">003864</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Levodopa‐dyskinesia incidence by age of Parkinson's disease onset</title>
<author>
<name sortKey="Kumar, Neeraj" sort="Kumar, Neeraj" uniqKey="Kumar N" first="Neeraj" last="Kumar">Neeraj Kumar</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Van Gerpen, Jay A" sort="Van Gerpen, Jay A" uniqKey="Van Gerpen J" first="Jay A." last="Van Gerpen">Jay A. Van Gerpen</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Ochsner Clinic, New Orleans, Louisiana</wicri:regionArea>
<placeName>
<region type="state">Louisiane</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-03">2005-03</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="342">342</biblScope>
<biblScope unit="page" to="344">344</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">218E7B52AA5A138757B5D46B9F3208CC4C6E7C11</idno>
<idno type="DOI">10.1002/mds.20360</idno>
<idno type="ArticleID">MDS20360</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Age of Onset</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cohort Studies</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson's disease</term>
<term>Retrospective Studies</term>
<term>age</term>
<term>levodopa‐induced dyskinesias</term>
<term>population</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Age of Onset</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We assessed the 5‐year risk of levodopa‐induced dyskinesias by age of Parkinson's disease (PD) onset in a population‐based cohort. The medical records linkage system of the Rochester Epidemiology project was used to identify residents of Olmsted County, Minnesota, with incident PD for the period 1976 through 1990. In this population‐based study, the 5‐year dyskinesia incidence declined with age. With PD onset after 70 years of age, the incidence was 16%. With onset from 40 to 59 years of age, the incidence was higher at 50%. These incidence data may overestimate the functional importance, because patients with minimal or reversible dyskinesias were counted. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Louisiane</li>
<li>Minnesota</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Minnesota">
<name sortKey="Kumar, Neeraj" sort="Kumar, Neeraj" uniqKey="Kumar N" first="Neeraj" last="Kumar">Neeraj Kumar</name>
</region>
<name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
<name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
<name sortKey="Van Gerpen, Jay A" sort="Van Gerpen, Jay A" uniqKey="Van Gerpen J" first="Jay A." last="Van Gerpen">Jay A. Van Gerpen</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003864 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003864 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:218E7B52AA5A138757B5D46B9F3208CC4C6E7C11
   |texte=   Levodopa‐dyskinesia incidence by age of Parkinson's disease onset
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024